Editorial: The gut-kidney axis: A potential drug target for treating kidney diseases

Front Pharmacol. 2022 Sep 7:13:1012890. doi: 10.3389/fphar.2022.1012890. eCollection 2022.

¹ Shenzhen Key Laboratory of Hospital Chinese Medicine Preparation, Shenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, China.
² Division of Life Science and Center for Chinese Medicine, The Hong Kong University of Science and Technology, Hong Kong, China.
³ Division of Nephrology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
⁴ Department of Pathology, University at Buffalo, Buffalo, NY, United States.

No abstract available

Keywords: gut microbiota; gut-kidney axis; kidney disease; microbial metabolism; therapeutic strategies.

Publication types